Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALT: Human Albumin Supplementation for Kidney Dysfunction After Liver Transplantation
NCT06535945Phase 4Recruiting
- Sponsor
- CHU Rennes
- Start
- Mar 2025
- Primary completion
- Apr 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in acute kidney injury (AKI), sponsored by CHU Rennes. Started Mar 2025; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06535945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06535945.